Ferenci, P., Caruntu, F. A., Lengyel, G., Messinger, D., Bakalos, G., & Flisiak, R. (2016). Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial. Infect Dis Ther.
Chicago Style citaatFerenci, Peter, Florin A. Caruntu, Gabriella Lengyel, Diethelm Messinger, Georgios Bakalos, en Robert Flisiak. "Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial." Infect Dis Ther 2016.
MLA citatieFerenci, Peter, et al. "Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial." Infect Dis Ther 2016.